Retrospective analysis of the clinical characteristics of adefovir dipivoxil–induced Fanconi’s syndrome in the Chinese population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrospective analysis of the clinical characteristics of adefovir dipivoxil–induced Fanconi’s syndrome in the Chinese population

Published:2020-05-14 Issue:4 Volume:45 Page:722-728
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Sun Linli¹^ORCID,Yi Dan²^ORCID,Sun Wei³^ORCID,Wang Chunjiang³^ORCID

Affiliation:

1. Department of general surgery The Third Xiangya Hospital Central South University Changsha China

2. Drug clinical trial center Zhuzhou central hospital Zhuzhou China

3. Department of Pharmacy The Third Xiangya Hospital Central South University Changsha China

Funder

Natural Science Foundation of Hunan Province

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13154

Reference37 articles.

1. Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016

2. Management of chronic hepatitis B infection

3. The hepatitis B epidemic in China should receive more attention

4. Chronic hepatitis B virus infection

5. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties;Fused Pyrimidine-Based Drug Discovery;2023

2. Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosis;World Chinese Journal of Digestology;2022-06-08

3. Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety;Basic & Clinical Pharmacology & Toxicology;2020-11-22

4. Short‑term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B;Biomedical Reports;2020-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3